The current PE ratio for Viemed Healthcare stock as of Jun 3, 2026 is 25.16. This is calculated based on the TTM EPS of $0.38 and the stock price of $9.56 per share. The PE ratio has grown by 22% from its last 4 quarters average of 20.6.
The average historical PE ratio of Viemed Healthcare for the last seven years is 26.4. The current P/E ratio of 25.16 is 4.7% lower than the historical average. Looking back at the last seven years, VMD's PE ratio peaked in the Mar 2023 quarter at 64.4, when the price was $9.66 and the EPS was $0.15. The lowest point was in the Dec 2020 quarter, when it reached 9.58 with a price of $7.76 and an EPS of $0.81.
Maximum annual increase: 136.95% in 2021
Maximum annual decrease: -64.47% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 19.55 | -29.32% | $7.43 | $0.38 |
| 2024 | 27.66 | -4.85% | $8.02 | $0.29 |
| 2023 | 29.07 | -38.48% | $7.85 | $0.27 |
| 2022 | 47.25 | 108.15% | $7.56 | $0.16 |
| 2021 | 22.7 | 136.95% | $5.22 | $0.23 |
| 2020 | 9.58 | -64.47% | $7.76 | $0.81 |
| 2019 | 26.96 | N/A | $6.2 | $0.23 |
| 2018 | N/A | N/A | N/A | $0.25 |
| 2017 | N/A | N/A | N/A | $0.22 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 24.24 | 23.99% | $9.21 | $0.38 |
| Dec 2025 | 19.55 | 0.77% | $7.43 | $0.38 |
| Sep 2025 | 19.4 | 1.09% | $6.79 | $0.35 |
| Jun 2025 | 19.19 | -15.65% | $6.91 | $0.36 |
| Mar 2025 | 22.75 | -17.75% | $7.28 | $0.32 |
| Dec 2024 | 27.66 | 1.88% | $8.02 | $0.29 |
| Sep 2024 | 27.15 | 3.63% | $7.33 | $0.27 |
| Jun 2024 | 26.2 | -24.99% | $6.55 | $0.25 |
| Mar 2024 | 34.93 | 20.16% | $9.43 | $0.27 |
| Dec 2023 | 29.07 | 3.67% | $7.85 | $0.27 |
| Sep 2023 | 28.04 | -45.52% | $6.73 | $0.24 |
| Jun 2023 | 51.47 | -20.08% | $9.78 | $0.19 |
| Mar 2023 | 64.4 | 36.3% | $9.66 | $0.15 |
| Dec 2022 | 47.25 | 49.62% | $7.56 | $0.16 |
| Sep 2022 | 31.58 | 23.26% | $6 | $0.19 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of VMD is lower than its 3 and 5-year averages.
Viemed Healthcare's price to earnings (P/E) of 25.16 is higher than the Healthcare sector average but lower than the industry average. In comparison with the Healthcare sector average of 23.02, Viemed Healthcare's price to earnings (P/E) is 9% higher.
In comparison to its peer PNTG, VMD's PE ratio is lower, but it is higher than OPCH's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPCH Option Care Health Inc | 15.56 | $3.15B |
| VMD Viemed Healthcare Inc | 25.95 | $378M |
| PNTG Pennant Group Inc | 33.83 | $1.05B |
As of Jun 3, 2026, VMD stock has a price to earnings ratio of 25.16.
The 3-year average price to earnings ratio for VMD stock is 27.47.
The 5-year average price to earnings ratio for VMD stock is 29.58.
Over the last seven years, the quarterly PE ratio reached its highest level at 64.4 in the Mar 2023 quarter.
The current PE ratio of VMD is 4.7% lower than the 7-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 3, 2026), Viemed Healthcare's share price is $9.56. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.38. Therefore, Viemed Healthcare's PE ratio for today is 25.16. PE RATIO(25.16) = STOCK PRICE($9.56) / TTM EPS($0.38)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.